ReviewFrontiers in immunology2018

Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases.

József Dobó et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.